Neoadjuvant ICI and Mitochondrial Vaccine for Resectable HNSCC

NCT07572864 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

BIOLOGICAL: Engineered Mitochondrial Vaccine (IMP3-Mito)
DRUG: Immune checkpoint inhibitor (ICI)

Sponsor

West China Hospital